glp-1 receptor agonist with dpp-4 inhibitor combination not recommended do combine inhibitors agonists guidance Why are DPP-4 ( Specific actions of GLP-1 receptor
Description
17 Could there be a similar effect from semaglutide and tirzepatide
DPP4 inhibitors primarily target the postprandial plasma glucose (PPG), whereas, GLP1 receptor agonists target fasting plasma glucose (FPG) as well as PPG
The greater impact on morbidity and mortality of diabetes in patients who develop the condition at a younger age compared to those who develop it later [77]
Diabetes care 27 (8), 18791884
For semaglutide, it is 0.25 mg, then 0.5 mg, then 1 mg, then 1.7 mg, then 2.4 mg
